Stomach Ulcer: all 114 studies
Page 2 of 2. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.CompletedNCT00367211Phase 3
- Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy VolunteersCompletedNCT00284908Phase 1
- Transnasal and Oral Gastroscopy.TerminatedNCT00273117
- Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication TherapyCompletedNCT00272467Phase 4
- Effect of Prevacid on Prostaglandin Levels in Patient With Stress UlcerCompletedNCT00239551Phase 4
- Cytokine Gene Polymorphisms in Gastric DiseasesStatus unknownNCT00197470Not applicable
- Pepsinogens as the Early Marker of H. Pylori EradicationCompletedNCT00197457Phase 2
- Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) InfectionStatus unknownNCT00197418Phase 2/3
- Pharmacogenetics of Gastrointestinal BleedingCompletedNCT00190255
- Lymphocytic Subsets and Cytokine Production With H. Pylori InfectionCompletedNCT00173953Not applicable
- Effect of Selective COX-2 Inhibition on Ulcer HealingCompletedNCT00153673Phase 3
- Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. PyloriStatus unknownNCT00149084Phase 3
- Helicobacter Pylori Eradication With a New Sequential TreatmentCompletedNCT00132171Phase 3
- A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole SodiumCompletedNCT00125736Phase 4